Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 286 AL 300

Gold standard assessment of delirium severity in patients with dementia: Evaluation of an expert panel adjudication process

Boockvar KS, Marcantonio ER, Price CC, Metzger ED, Tommet D, Schmitt EM, Heine C, Topper M, Jones RN, Fong TG, Inouye SK; BASIL-II Study Group.

J Alzheimers Dis. 2026 Apr;110(3):1204-1213. doi: 10.1177/13872877261422418. Epub 2026 Mar 12.

Linking sleep apnea and arthritis in the National Alzheimer Coordinating Center Cohort: A cross-sectional analysis

Irfan B, Pal S, Reader J, Bakulski KM, Paulson H, Giordani B.

Medicine (Baltimore). 2026 Feb 20;105(8):e47717. doi: 10.1097/MD.0000000000047717.

[Efficacy of choline alfoscerate treatment for subjective cognitive impairment in first-degree relatives of patients with Alzheimer's disease: Results of a comparative 5-year study]

Selezneva ND, Roshchina IF, Gavrilova SI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):92-99. doi: 10.17116/jnevro202612604292.

Artificial intelligence for detection and staging of Alzheimer's disease using retinal images

Panjwani M, Holmes JM, Liu SH, Lee E, Rapcsak S, Harris A, Kozak I.

Cochrane Database Syst Rev. 2026 May 21;5(5):CD016358. doi: 10.1002/14651858.CD016358.

Examining adverse effects in a large clinical trial of rTMS application as a treatment for Alzheimer's disease

Uehara MA, Bretecher CA, Teschuk JM, Verot A, Saha C, Fitzgerald PB, Koski L, Millikin C, Moussavi Z.

Psychiatry Res. 2026 Aug;362:117212. doi: 10.1016/j.psychres.2026.117212. Epub 2026 May 4.

Soluble and plaque amyloid associations with peripheral glucose dysregulation modulated by tau pathology in Alzheimer's disease

Kang DW, Kim S, Kim S, Um YH, Wang SM, Ha S, Park SY, Lee SH, Choe YS, Kim D, Lee CU, Lim HK.

J Prev Alzheimers Dis. 2026 Feb;13(2):100459. doi: 10.1016/j.tjpad.2025.100459. Epub 2026 Jan 1.

Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum

Park J, Kwon HJ, Joo J, Jang H, Seo SW, Na DL, Jung NY; for Precision medicine platform for MCI based on Multi-omics, Imaging, Evidence-based R&BD (PREMIER) Consortium.

J Alzheimers Dis. 2026 May;111(1):312-323. doi: 10.1177/13872877261431795. Epub 2026 Mar 26.

The forgotten population: Early-onset Alzheimer's in people with Down syndrome

Oliveira MC.

Alzheimers Dement. 2026 Apr;22(4):e71311. doi: 10.1002/alz.71311.

Multidimensional cognitive deficit in logopenic variant primary progressive aphasia: a case report

Puspitasari V, Ramli Y, Lastri DN, Prawiroharjo P, Wijaya JH.

J Med Case Rep. 2026 May 29;20(1):302. doi: 10.1186/s13256-026-06137-1.

Culturally and linguistically diverse patients in an Italian memory clinic: lessons learned from the ImmiDem project

Cova I, Maestri G, Nicotra A, Forgione A, Maggiore L, Acampora A, Canevelli M, Vanacore N, Pantoni L, Pomati S.

Neurol Sci. 2026 Feb 24;47(3):285. doi: 10.1007/s10072-026-08860-5.

Language performances in dementia with Lewy bodies and Alzheimer's disease: A longitudinal comparative study of naming and fluency

Labernède F, Lausecker A, Sanna L, Philippi N, Demuynck C, Cretin B, Muller C, Blanc F, Chabran É.

J Alzheimers Dis. 2026 Apr;110(4):1870-1885. doi: 10.1177/13872877261427500. Epub 2026 Mar 26.

Advanced diffusion MRI tract signatures in Alzheimer's disease, dementia with Lewy bodies, and the FTD/PPA spectrum

Tian Y, Whitwell JL.

Neuroimage. 2026 Jul 1;334:121984. doi: 10.1016/j.neuroimage.2026.121984. Epub 2026 May 8.

Tools to Measure Noncognitive Symptoms in Nursing Home Residents With Advanced Dementia: A Scoping Review

Faherty MM, O'Mahony LA, Kenny LD, Cornally N, Brady NM, Dalton O'Connor C, Fox S, Hartigan I, van der Steen JT, Timmons S.

J Am Med Dir Assoc. 2026 Apr;27(4):106133. doi: 10.1016/j.jamda.2026.106133. Epub 2026 Mar 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias